Literature DB >> 30017388

The impact of IL-10 dynamic modulation on host immune response against visceral leishmaniasis.

Inês Mesquita1, Carolina Ferreira1, Ana Margarida Barbosa1, Catarina Machado Ferreira1, Diana Moreira1, Agostinho Carvalho1, Cristina Cunha1, Fernando Rodrigues1, Ricardo Jorge Dinis-Oliveira2, Jérôme Estaquier3, António Gil Castro1, Egídio Torrado1, Ricardo Silvestre4.   

Abstract

Leishmaniasis is a vector-borne disease caused by protozoan parasites from the genus Leishmania. The most severe form of disease is visceral leishmaniasis (VL), which is fatal if left untreated. It has been demonstrated that interleukin (IL)-10, is associated with disease progression and susceptibility. In this work, we took advantage of a transgenic mouse model that expresses high levels of IL-10 upon zinc sulfate administration (pMT-10). We addressed the role of IL-10 during the initial stages of L. donovani infection by analyzing the parasite burden in the spleen and liver of the infected pMT-10 and WT mice as well as the histopathological alterations upon IL-10 induction. Furthermore, the profile of cytokines expressed by T cells was assessed. Our results demonstrate that an increase in IL-10 production has an impact early but not later after infection. This specific temporal role for IL-10-mediated susceptibility to VL is of interest.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IFN-γ; IL-10; Multifunctional CD4(+) T cells; Visceral leishmaniasis

Mesh:

Substances:

Year:  2018        PMID: 30017388     DOI: 10.1016/j.cyto.2018.07.001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation.

Authors:  Nektarios Barabutis; Mohammad A Uddin; John D Catravas
Journal:  Cytokine       Date:  2018-11-09       Impact factor: 3.861

2.  Leucocytes and Th-associated Cytokine Profile of HIV-Leishmaniasis Co-Infected Persons Attending Abuja Teaching Hospital, Nigeria.

Authors:  Idris Nasir Abdullahi; Anthony Uchenna Emeribe; Hafeez Aderinsayo Adekola; Habiba Yahaya Muhammad; Abdurrahman El-Fulaty Ahmad; Abubakar Umar Anka; Yusuf Mohammed; Shamsuddeen Haruna; Bamidele Soji Oderinde; Halima Ali Shuwa; Adamu Babayo
Journal:  Eurasian J Med       Date:  2020-10

3.  Evaluation of In vitro and In vivo Protective Efficacy of Bauhinia variegata Against Leishmania donovani in Murine Model.

Authors:  Gurpreet Kaur; Kalpana Chauhan; Namrata Anand; Sukhbir Kaur
Journal:  Acta Parasitol       Date:  2021-02-02       Impact factor: 1.440

4.  Case Report: Severe Visceral Leishmaniasis in a Patient with HIV Coinfection Undergoing Treatment for Erythema Nodosum Leprosum.

Authors:  Samuel R Aquino; Lucyo F B Diniz; Igor T Queiroz; Mirella A Cunha; Alda M Justo; Elis D Silva; Valéria R A Pereira; Zulma M Medeiros; Rodrigo F Carmo
Journal:  Am J Trop Med Hyg       Date:  2020-09-03       Impact factor: 3.707

Review 5.  Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Authors:  Alti Dayakar; Sambamurthy Chandrasekaran; Suresh V Kuchipudi; Suresh K Kalangi
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

6.  Non-human primates and Leishmania immunity.

Authors:  Sonia André; Vasco Rodrigues; Morgane Picard; Ricardo Silvestre; Jérôme Estaquier
Journal:  Cytokine X       Date:  2020-10-12

Review 7.  Revival of Leishmanization and Leishmanin.

Authors:  Thalia Pacheco-Fernandez; Greta Volpedo; Sreenivas Gannavaram; Parna Bhattacharya; Ranadhir Dey; Abhay Satoskar; Greg Matlashewski; Hira L Nakhasi
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

Review 8.  Role of Cytokines in Experimental and Human Visceral Leishmaniasis.

Authors:  Mukesh Samant; Utkarsha Sahu; Satish Chandra Pandey; Prashant Khare
Journal:  Front Cell Infect Microbiol       Date:  2021-02-18       Impact factor: 5.293

9.  Liver- and Spleen-Specific Immune Responses in Experimental Leishmania martiniquensis Infection in BALB/c Mice.

Authors:  Woraporn Sukhumavasi; Theerayuth Kaewamatawong; Nawaphat Somboonpoonpol; Montakan Jiratanh; Juntra Wattanamethanont; Morakot Kaewthamasorn; Saovanee Leelayoova; Saruda Tiwananthagorn
Journal:  Front Vet Sci       Date:  2021-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.